Whole-process case management effects on mental state and self-care ability in patients with liver cancer
CONCLUSION: Whole-process case management can effectively reduce anxiety and depression in patients with liver cancer, alleviate symptoms and problems, and improve the level of hope, self-care ability, sleep quality, and quality of life, as well as provide feasible nursing alternatives for patients with liver cancer.PMID:38577082 | PMC:PMC10989342 | DOI:10.4240/wjgs.v16.i3.833 (Source: Cancer Control)
Source: Cancer Control - April 5, 2024 Category: Cancer & Oncology Authors: Man-Di Ju Qin Qin Meng Li Source Type: research
circular RNA circ-231 promotes protein biogenesis of TPI1 and PRDX6 through mediating the interaction of eIF4A3 with STAU1 to facilitate unwinding of secondary structure in 5' UTR, enhancing progression of human esophageal squamous cell carcinoma (ESCC)
Conclusions: Our data unravels the detailed mechanism by which STAU1 binds to secondary structure in 5' UTR of mRNAs and recruits eIF4A3 through interacting with circ-231 and thereby eIF4A3 is implicated in unwinding of secondary structure, which is common to HEK293T and ESCC. However, importantly, our data reveals that circ-231 promotes migration and proliferation of ESCC and the up-regulated circ-231 greatly correlates with tumor lymph node metastasis, insinuating that circ-231 could be a therapeutic target and an indicator of risk of lymph node metastasis for patients with ESCC.PMID:38577609 | PMC:PMC10988296 | DOI:10.7...
Source: Cancer Control - April 5, 2024 Category: Cancer & Oncology Authors: Guo-Wei Huang Ti-Qun Yang Qian-Qian Chen Xing-Mu Liu Ling-Hui Xie Wei Huang Xue-Ling Chen Yi-Qun Geng Jiang Gu Source Type: research
Research progress on oncoprotein hepatitis B X ‑interacting protein (Review)
In conclusion, the present review summarized the existing knowledge of HBXIP, established its carcinogenic mechanism and discussed future related research on HBXIP.PMID:38577934 | DOI:10.3892/mmr.2024.13213 (Source: Molecular Medicine)
Source: Molecular Medicine - April 5, 2024 Category: Molecular Biology Authors: Lei Cheng Lijuan Guo Teng Zou Yisong Yang Ran Tao Shuangping Liu Source Type: research
Research progress on oncoprotein hepatitis B X ‑interacting protein (Review)
In conclusion, the present review summarized the existing knowledge of HBXIP, established its carcinogenic mechanism and discussed future related research on HBXIP.PMID:38577934 | DOI:10.3892/mmr.2024.13213 (Source: Molecular Medicine Reports)
Source: Molecular Medicine Reports - April 5, 2024 Category: Molecular Biology Authors: Lei Cheng Lijuan Guo Teng Zou Yisong Yang Ran Tao Shuangping Liu Source Type: research
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology
CONCLUSION: The use of G-CSF for primary prophylaxis in chemotherapy for colorectal cancer is inappropriate.PMID:38578596 | DOI:10.1007/s10147-024-02502-6 (Source: Clinical Breast Cancer)
Source: Clinical Breast Cancer - April 5, 2024 Category: Cancer & Oncology Authors: Mamoru Ito Yuta Okumura Kenta Nio Eishi Baba Yukinori Ozaki Hiroshi Nishio Eiki Ichihara Yuji Miura Makoto Endo Shingo Yano Dai Maruyama Tetsuhiro Yoshinami Nobuyuki Susumu Munetaka Takekuma Takashi Motohashi Nobuaki Ochi Toshio Kubo Keita Uchino Takahiro Source Type: research
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology
CONCLUSION: The use of G-CSF for primary prophylaxis in chemotherapy for colorectal cancer is inappropriate.PMID:38578596 | DOI:10.1007/s10147-024-02502-6 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - April 5, 2024 Category: Cancer & Oncology Authors: Mamoru Ito Yuta Okumura Kenta Nio Eishi Baba Yukinori Ozaki Hiroshi Nishio Eiki Ichihara Yuji Miura Makoto Endo Shingo Yano Dai Maruyama Tetsuhiro Yoshinami Nobuyuki Susumu Munetaka Takekuma Takashi Motohashi Nobuaki Ochi Toshio Kubo Keita Uchino Takahiro Source Type: research
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology
CONCLUSION: The use of G-CSF for primary prophylaxis in chemotherapy for colorectal cancer is inappropriate.PMID:38578596 | DOI:10.1007/s10147-024-02502-6 (Source: Clinical Colorectal Cancer)
Source: Clinical Colorectal Cancer - April 5, 2024 Category: Cancer & Oncology Authors: Mamoru Ito Yuta Okumura Kenta Nio Eishi Baba Yukinori Ozaki Hiroshi Nishio Eiki Ichihara Yuji Miura Makoto Endo Shingo Yano Dai Maruyama Tetsuhiro Yoshinami Nobuyuki Susumu Munetaka Takekuma Takashi Motohashi Nobuaki Ochi Toshio Kubo Keita Uchino Takahiro Source Type: research
Research progress on oncoprotein hepatitis B X ‑interacting protein (Review)
In conclusion, the present review summarized the existing knowledge of HBXIP, established its carcinogenic mechanism and discussed future related research on HBXIP.PMID:38577934 | DOI:10.3892/mmr.2024.13213 (Source: Molecular Medicine)
Source: Molecular Medicine - April 5, 2024 Category: Molecular Biology Authors: Lei Cheng Lijuan Guo Teng Zou Yisong Yang Ran Tao Shuangping Liu Source Type: research
Research progress on oncoprotein hepatitis B X ‑interacting protein (Review)
In conclusion, the present review summarized the existing knowledge of HBXIP, established its carcinogenic mechanism and discussed future related research on HBXIP.PMID:38577934 | DOI:10.3892/mmr.2024.13213 (Source: Molecular Medicine Reports)
Source: Molecular Medicine Reports - April 5, 2024 Category: Molecular Biology Authors: Lei Cheng Lijuan Guo Teng Zou Yisong Yang Ran Tao Shuangping Liu Source Type: research
Understanding the malignant potential of gastric metaplasia of the oesophagus and its relevance to Barretts oesophagus surveillance: individual-level data analysis
Conclusion
SS-GM is a distinct entity from SS-IM and the malignant potential of GM is lower than IM. It is questionable whether SS-GM warrants inclusion in BO surveillance. (Source: Gut)
Source: Gut - April 5, 2024 Category: Gastroenterology Authors: Black, E. L., Ococks, E., Devonshire, G., Ng, A. W. T., ODonovan, M., Malhotra, S., Tripathi, M., Miremadi, A., Freeman, A., Coles, H., Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium, Fitzgerald, R. C., Fitzgerald, Nutzinger, Tags: Open access, Gut Oesophagus Source Type: research
Refining definitions of Barretts oesophagus to improve clinical resource utilisation
Oesophageal adenocarcinoma (OAC) is a devastating disease with an average 5-year survival of around 15%.1 Moreover, rates of OAC have increased substantially in recent decades, adding greatly to the clinical and economic burden of this disease.2 OAC arises out of a metaplastic precursor in which the normal squamous lining of the oesophagus is replaced with columnar, mucin-secreting cells. This is termed Barrett’s oesophagus (BO) and is thought to form as a protective mechanism in response to gastro-oesophageal reflux disease (GORD). The cells that make up this oesophageal metaplasia can take several forms, roughly be...
Source: Gut - April 5, 2024 Category: Gastroenterology Authors: Stachler, M. D., Ain, Q. U. Tags: Gut Commentary Source Type: research
